↓ Skip to main content

Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial

Overview of attention for article published in BMC Endocrine Disorders, August 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial
Published in
BMC Endocrine Disorders, August 2020
DOI 10.1186/s12902-020-00610-8
Pubmed ID
Authors

Jacob Jewson, Elisabeth Lambert, Carolina Sari, Eveline Jona, Soulmaz Shorakae, Gavin Lambert, Jamie Gaida

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 11%
Student > Master 7 10%
Researcher 4 6%
Student > Ph. D. Student 4 6%
Student > Doctoral Student 3 4%
Other 5 7%
Unknown 39 56%
Readers by discipline Count As %
Nursing and Health Professions 12 17%
Medicine and Dentistry 6 9%
Sports and Recreations 4 6%
Biochemistry, Genetics and Molecular Biology 2 3%
Arts and Humanities 1 1%
Other 5 7%
Unknown 40 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2021.
All research outputs
#6,370,681
of 23,232,430 outputs
Outputs from BMC Endocrine Disorders
#193
of 784 outputs
Outputs of similar age
#137,201
of 399,261 outputs
Outputs of similar age from BMC Endocrine Disorders
#7
of 22 outputs
Altmetric has tracked 23,232,430 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 784 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,261 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.